Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach

Archives of Toxicology

Volumn 80, Issue 10, 2006, Pages 713-718

  Stier, Sebastian ^a   Neuhaus, Thomas ^a   Albers, Peter ^b   Wernert, Nicolas ^c   Grünewald, Elisabeth ^a   Forkert, Randolf ^a   Vetter, Hans ^a   Ko, Yon ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b KLINIKUM KASSEL   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

H19; IGF2; Loss of imprinting; Real time PCR; Testicular seminomas

Indexed keywords

RNA H19; SOMATOMEDIN B;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENOME IMPRINTING; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEMINOMA;

EID: 33748688615     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0087-z     Document Type: Article

References (37)

1. Brüning T, Abel J, Koch B, Lorenzen K, Harth V, Donat S, Sachinidis A, Vetter H, Bolt HM, Ko Y (1999) Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism. Arch Toxicol 73:427-430
2. Burns JL, Jackson DA, Hassan AB (2001) A view through the clouds of imprinting. FASEB J 15:1694-1703
3. Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY (2000) Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Clin Cancer Res 6:474-479
4. Christofori G, Naik P, Hanahan D (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418
5. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4:1276-1280
6. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP (2003) Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299:1753-1755
7. DeChiara TM, Robertson EJ, Efstratiadis A (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859
8. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G (1996) High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12:423-430
9. Fukuzawa R, Umezawa A, Ochi K, Urano F, Ikeda H, Hata J (1999) High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma. Int J Cancer 82:490-497
10. Goodman JI, Watson RE (2002) Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 42:501-525
11. van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH (1994) Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075
12. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993) Tumour-suppressor activity of H19 RNA. Nature 365:764-767
13. Harth V, Donat S, Ko Y, Abel J, Vetter H, Brüning T (2000) NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer. Arch Toxicol 73:528-531
14. Jirtle RL (1999) Genomic imprinting and cancer. Exp Cell Res 248:18-24
15. Ko Y, Koch B, Harth V, Sachinidis A, Thier R, Vetter H, Bolt HM, Brüning T (2000) Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction. Pharmacogenetics 10:271-274
16. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T (1995) Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10:1193-1198
17. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekstrom TJ (1995) Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 11:221-229
18. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T et al (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 7:440-447
19. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A (2001) Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 98:591-596
20. Narayan S, Roy D (2003) Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2:41
21. Neuhaus T, Geisen G, Bolt HM, Janzen V, Kraemer A, Vetter H, Ko Y (2004) Reliability of non-invasively acquired human genomic DNA as a substrate for real-time PCR assisted analysis of genetic polymorphisms. Arch Toxicol 78(7):390-396
22. Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A (1997a) Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. J Urol 157:1977-1979
23. Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M, Okuyama A (1997b) Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma. Cancer Res 57:2575-2577
24. O'Dell SD, Day IN (1998) Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30:767-771
25. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751
26. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedborg F, Schofield P, Flam F, Ekstrom TJ (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet 4:94-97
27. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747-749
28. Reik W, Murrell A (2000) Genomic imprinting. Silence across the border. Nature 405:408-409
29. Sandovici I, Leppert M, Hawk PR, Suarez A, Linares Y, Sapienza C (2003) Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum Mol Genet 12:1569-1578
30. Schofield PN (1991) Molecular biology of the insulin-like growth factors: gene structure and expression. Acta Paediatr Scand Suppl 372:83-90; discussion 91
31. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 7:433-439
32. Thorvaldsen JL, Duran KL, Bartolomei MS (1998) Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev 12:3693-3702
33. Vu TH, Yballe C, Boonyanit S, Hoffman AR (1995) Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab 80:1670-1676
34. Werner H, LeRoith D (1996) The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68:183-223
35. Zhan S, Shapiro DN, Helman LJ (1994) Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 94:445-448
36. Zhan S, Shapiro DN, Helman LJ (1995) Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 11:2503-2507
37. Zhang Y, Tycko B (1992) Monoallelic expression of the human H19 gene. Nat Genet 1:40-44